Chembio Diagnostics (CEMI) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Climate Change Environment Environmental Environmental Protection Green Hazard Materials Nature Offset Package Packaging Pandemic Raw Materials Recycling Regenerative Renewable Scarcity Access Benefits Black Collective Bargaining Community Customer Cyber Cybersecurity Data Security Death Disability Diversity Employee Employee Retention Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Incident Injuries Injury Minimum Wage Overtime Privacy Product Quality Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skills Social Society Supplier Supply Chain Supply Chain Management Training Union Women Workers Workforce Working Condition Anti-corruption Assessment Assurance Audit Board Oversight Bonus Bribe Bribery Class Action Lawsuit Classified Classified Board Clawback Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Independent Chair Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Overboarding Oversee Oversight Plaintiff Procurement Purpose Quality Standard R&D Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Tenure Term Limit Transparency Transparent

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

We held our 2021 Annual Meeting of Stockholders on June 25, 2021. The board of directors solicited proxies pursuant to a proxy statement that we filed on May 13, 2021 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934. There was no solicitation in opposition to the board’s solicitation.

At the meeting, holders of common stock were asked to consider and vote upon the four proposals set forth below. Each share of common stock was entitled to one vote with respect to each matter submitted to a vote at the meeting. Shares of common stock representing 12,620,504, or 62.34% of the total votes attributable to all outstanding shares of common stock, were present in person or by proxy at the meeting.

The voting results reported below are final.

The matters considered and voted on by the stockholders at the meeting and the votes of the stockholders were as follows:

Proposal 1.

Stockholders voted as follows with respect to the election of each of the nominees for director identified in the proxy statement:

Nominee	For	Withhold	Broker Non-Votes
David W.K. Acheson	6,218,403	418,685	5,983,416
David W. Bespalko	6,183,939	453,149	5,983,416
Katherine L. Davis	4,210,823	2,426,265	5,983,416
Richard L. Eberly	5,445,668	1,191,420	5,983,416
John G. Potthoff	5,276,667	1,360,421	5,983,416

As a result of this vote, each of the five nominees was elected as a director to serve until the 2022 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified.

Proposal 2.

Stockholders voted as follows with respect to approval of the amendment to the Chembio Diagnostics, Inc. 2019 Omnibus Incentive Plan:

	For	Against	Abstain	Broker Non-Votes
Approval of amendment to the 2019 Omnibus Incentive Plan	4,309,726	1,621,024	706,336	5,983,416

Proposal 3.

Stockholders ratified the appointment of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2021, by the following vote:

	For	Against	Abstain	Broker Non-Votes
Ratification of appointment of Ernst & Young LLP	11,781,592	359,566	479,346	—

Proposal 4.

Stockholders approved, on a non-binding advisory basis, the compensation paid to our executive officers in 2020, as disclosed in the 2021 proxy statement, by the following vote:

	For	Against	Abstain	Broker Non-Votes
Advisory vote on 2020 executive compensation	5,618,506	814,997	203,585	5,983,416